You are here: Industry Insights > Acquisition

News List

Applied Materials Acquires Perceptive Engineering PharmaSources.com
November 11, 2020
Applied Materials has acquired Perceptive Engineering Ltd., headquartered in Manchester, UK, a leader in advanced process control and model predictive control in the pharmaceutical industry.
PerkinElmer to Acquire Cell Engineering Company Horizon Discovery americanpharmaceuticalreview
November 06, 2020
PerkinElmer and Horizon Discovery Group have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire Horizon for approximately $383 million (£296 million).
Aurobindo Pharma to divest Natrol to New Mountain Capit expresspharma
October 28, 2020
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an affiliate of New Mountain Capital to combine with Jarrow Formulas.
Gilead Sciences acquires Immunomedics in $21bn deal pharmaceutical-technology
October 28, 2020
Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn.
Endo International agrees to acquire BioSpecifics Technologies for $540m pharmaceutical-technology
October 22, 2020
Endo International has agreed to acquire BioSpecifics Technologies in a cash-based transaction valued at approximately $540m.
UCB acquires new campus to support UK operations pharmatimes
October 22, 2020
Belgian pharma company UCB has agreed to acquire a new campus to further support its operations in the UK.
Powder Flow:MICROMERITICS INSTRUMENT CORP. ACQUIRES FREEMAN TECHNOLOGY Freeman Technology
October 21, 2020
Micromeritics Instrument Corporation, a leading global manufacturer of premium products for advanced material characterisation, today announced the acquisition of Freeman Technology.
Astellas to acquire iota Biosciences following R&D partnership pharmatimes
October 19, 2020
Japanese pharma Astellas will acquire bioelectronics firm iota after announcing a research and development agreement last year.
Eli Lilly to acquire biotechnology company Disarm Therapeutics pharmaceutical-technology
October 19, 2020
Eli Lilly has entered a definitive agreement to acquire biotech firm Disarm Therapeutics for an upfront payment of $135m.
HitGen to acquire Vernalis for $25 mn in cash expresspharma
October 14, 2020
The closing of this transaction is subject to customary conditions and approvals, expected to complete before the end of 2020.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page